Assessment of response to treatment
| Response to treatment . | At 6 months . | At 18 months . | ||
|---|---|---|---|---|
| Number (%) . | Number (%) . | |||
| CHVP+I . | R-CHVP+I . | CHVP+I . | R-CHVP+I . | |
| Complete response | 29 (16) | 63 (36) | 71 (39) | 90 (51) |
| Unconfirmed complete response | 33 (18) | 47 (27) | 20 (11) | 28 (16) |
| Partial response | 94 (51) | 54 (31) | 40 (22) | 24 (14) |
| Stable disease | 9 (5) | 2 (1) | 3 (2) | 1 (1) |
| Disease progression | 18 (10) | 8 (5) | 47 (26) | 31 (18) |
| Death | 0 (0) | 1 (1) | 2 (1) | 1 (1) |
| P value | <.001 | =.035 | ||
| Response to treatment . | At 6 months . | At 18 months . | ||
|---|---|---|---|---|
| Number (%) . | Number (%) . | |||
| CHVP+I . | R-CHVP+I . | CHVP+I . | R-CHVP+I . | |
| Complete response | 29 (16) | 63 (36) | 71 (39) | 90 (51) |
| Unconfirmed complete response | 33 (18) | 47 (27) | 20 (11) | 28 (16) |
| Partial response | 94 (51) | 54 (31) | 40 (22) | 24 (14) |
| Stable disease | 9 (5) | 2 (1) | 3 (2) | 1 (1) |
| Disease progression | 18 (10) | 8 (5) | 47 (26) | 31 (18) |
| Death | 0 (0) | 1 (1) | 2 (1) | 1 (1) |
| P value | <.001 | =.035 | ||
Assessment of response to treatment after 6 and 18 months, respectively, of therapy observed in 358 patients in the FL2000 study in each study arm. The actual number of patients with each response status is reported with the percentages according to the whole study population. The P value was obtained using a global χ2 test for all strata.